United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$563.37
-7.07%
Mkt Cap $25.15B
Analyst Ratings
Buy
12
Hold
2
Sell
0
Price Target (39 analysts)
$650.00
Range $515.00 – $735.00
Implied Upside
+15.4%
Consensus $650.00 vs current $563.37